nach oben

Breast Cancer Research and Treatment

Erschienen in:

01.12.2007 | Review

Is radiofrequency ablation treatment for small breast cancer ready for “prime time”?

verfasst von: Masakuni Noguchi

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

There is increasing demand for minimally invasive and non-surgical treatment methods for patients with small breast cancer. Radiofrequency (RF) ablation is the most promising among several non-surgical ablation techniques in the treatment of breast cancer. Several pilot studies of RF ablation therapy are currently in progress in Japan as well as USA. However, non-surgical ablation techniques still have a number of problems with regard to (a) inability to precisely determine tumor size, (b) determination of 100% tumor cell killing, (c) ability to follow local recurrence, and (d) cosmetic outcome. To achieve wide acceptance, non-surgical ablation techniques must achieve results equivalent to those of conventional breast conserving treatment (BCT) in local control and survival. This paper reviews and discusses the practical applicability and relevance of RF ablation treatment for small breast cancer.

Noguchi M (2003) Minimally invasive surgery for small breast cancer? (Review). J Surg Oncol 84:94–101PubMedCrossRef

Singletary SE (2003) Radiofrequency ablation of breast cancer. Am Surg 69:37–40PubMed

Noguchi M (2003) Radiofrequency ablation treatment for breast cancer to meet the next challenge: how to treat primary breast tumor without surgery. Breast Cancer 10:203–205

Jeffrey SS, Birdwell RL, Ikeda DM, Daniel BL, Nowels KW, Dirbas FM, Griffey SM (1999) Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch Surg 134:1064–1068PubMedCrossRef

Izzo F, Thomas R, Delrio P, Rinaldo M, Vallone P, DeChiara A, Botti G, D’Aiuto G, Cortino P, Curley SA (2001) Radiofrequency ablation in patients with primary breast carcinoma. A pilot study in 26 patients. Cancer 92:2036–2044PubMedCrossRef

Elliott RL, Rice PB, Suits JA, Ostrowe AJ, Head JF (2002) Radiofrequency ablation of a stereotactically localized nonpalpable breast carcinoma. Am Surg 68:1–5PubMed

Burak WE Jr, Agnese DM, Povoski SP, Yanssens TL, Bloom KJ, Wakely PE, Spigos DG (2003) Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision. Cancer 98:1369–1376PubMedCrossRef

Hayashi AH, Silver SF, van der Westhuizen NG, Donald JC, Parker C, Fraser S, Ross AC, Olivotto IA (2003) Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation. Am J Surg 185:429–435PubMedCrossRef

Fornage BD, Sneige N, Ross MI, Mirza AN, Kuerer HM, Edeiken BS, Ames FC, Newman LA, Babiera GV, Singletary SE (2004) Small (≤2 cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology 231:215–224PubMedCrossRef

10.

Noguchi M, Earashi M, Fujii H, Yokoyama K, Harada K, Tsuneyama K (2006) Radiofrequency ablation of small breast cancer followed by surgical resection. J Surg Oncol 93:120–128PubMedCrossRef

11.

Copeland EM III, Bland KI (2004) Are minimally invasive techniques for ablation of breast cancer ready for “prime time”? Ann Surg Oncol 11(2):115–116PubMedCrossRef

12.

Morrow M (2006) Current controversies in the local therapy of breast cancer: margins and non surgical ablation. In: The proceeding of the 14th annual meeting of the Japanese breast cancer society, Kanazawa, Japan, pp 144–145

13.

Fletcher GH (1984) Subclinical disease. Cancer 53:1274–1284PubMedCrossRef

14.

Golshan M, Fung BB, Wiley E, Wolfman J, Rademaker A, Morrow M (2004) Prediction of breast cancer size by ultrasound, mammography and core biopsy. Breast 13:265–271PubMedCrossRef

15.

Esserman L, Hylton N, Yassa L, Barclay J, Frankel S, Sickles E (1999) Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 17:110–119PubMed

16.

Hata T, Takahashi H, Watanabe K, Takahashi M, Taguchi K, Itoh T, Todo S (2004) Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasound. J Am Coll Surg 198:190–197PubMedCrossRef

17.

Bedrosian I, Mick R, Orel SG, Schnall M, Reynolds C, Spitz FR, Callans LS, Buzby GP, Rosato EF, Fraker DL, Czerniecki BJ (2003) Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 98:468–473PubMedCrossRef

18.

Tillman GF, Orel SG, Schnall MD, Schultz DJ, Tan JE, Solin LJ (2002) Effect of breast magnetic resonance imaging on the clinical management of women with early stage breast carcinoma. J Clin Oncol 203:3413–3423CrossRef

19.

Van Goethem M, Tjalma W, Schelfout K, Verslegers I, Biltjes I, Parizel P (2006) Magnetic resonance imaging in breast cancer. Eur J Surg Oncol [Epub ahead of print]

20.

Morrow M (2004) Magnetic resonance imaging in the preoperative evaluation of breast cancer: primum non nocere. J Am Coll Surg 198:240–241PubMedCrossRef

21.

Earashi M, Noguchi M, Motoyoshi A, Fujii H (2007) Radiofrequency ablation therapy for small breast cancer followed by immediate surgical resection or delayed mammotome excision. Breast Cancer 14:39–47PubMedCrossRef

22.

Noguchi M, Minami M, Earashi M, Taniya T, Miyazaki I, Mizukami Y, Nonomura A (1995) Intraoperative histologic assessment of surgical margins and lymph node metastasis in breast-conserving surgery. J Surg Oncol 60:185–190PubMedCrossRef

23.

Klimberg VS, Kepple J, Shafirstein G, Adkins L, Henry-Tillman R, Youssef E, Brito J, Talley L, Korourian S (2006) eRFA: excision followed by RFA—a new technique to improve local control in breast cancer. Ann Surg Oncol 13(11):1422–1433PubMedCrossRef

24.

Fine RE, Staren ED (2006) Percutaneous radiofrequency-assisted excision of fibroadenomas. Am J Surg 192:545–547PubMedCrossRef

25.

Mirza AN, Fornage BD, Sneige N, Kuerer HM, Newman LA, Ames FC, Singletary SE (2001) Radiofrequency ablation of solid tumors. Cancer J 7:95–102PubMed

26.

Simmons RM, Dowlatshahi K, Singletary SE, Staren ED (2002) Ablative therapies for breast cancer. Contemp Surg 58:61–72

27.

Wazer DE, DiPetrillo T, Schmidt-Ullrich R, Weld L, Smith TJ, Marchant DJ, Robert NJ (1992) Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 10:356–363PubMed

28.

Noguchi M, Minami M, Earashi M, Taniya T, Miyazaki I, Nishijima H, Takanaka T, Kawashima H, Saito Y, Nakamura S, Mizukami Y, Nonomura A, Michigishi T, Yokoyama K (1995) Oncologic and cosmetic outcome in patients with breast cancer treated with wide excision, transposition of adipose tissue with latissimus dorsi muscle, and axillary dissection followed by radiotherapy. Breast Cancer Res Treat 35:163–171PubMedCrossRef

29.

Tamaki T, Oura S, Yoshimatsu T, Ohta F, Shimizu Y, Okamura Y (2006) Radiofrequency ablation therapy in 100 patients: its safety and short-term outcome (abstract in Japanese), J Jpn Surg Assoc 67(Suppl):305

30.

Drew PJ, Kerin MJ, Turnbull LW, Imrie M, Carleton PJ, Fox JN, Monson JR (1998) Routine screening for local recurrence following breast-conserving therapy for cancer with dynamic contrast-enhanced magnetic resonance imaging of the breast. Ann Surg Oncol 5:263–270CrossRef

31.

LaTrenta LR, Menell JH, Morris EA, Abramson AF, Dershaw DD, Liberman L (2003) Breast lesions detected with MR Imaging: utility and histopathologic importance of identification with US. Radiology 227:856–861PubMedCrossRef

32.

Marcy PY, Magne N, Castadot P, Bailet C, Namer M (2006) Ultrasound-guided percutaneous radiofrequency ablation in elderly breast cancer patients: preliminary institutional experience. Br J Radiol [Epub ahead of print]

Titel: Is radiofrequency ablation treatment for small breast cancer ready for “prime time”?
verfasst von: Masakuni Noguchi
Publikationsdatum: 01.12.2007
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 3/2007
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-007-9515-x

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Is radiofrequency ablation treatment for small breast cancer ready for “prime time”?

Abstract

Neu im Fachgebiet Onkologie

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

Update Onkologie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2007

Increased abdominal girth in a 29-year-old breast cancer patient with extensive liver metastasis and presumed chemotherapy induced amenorrhea. A case report and review of the literature

The neuronal guidance cue Slit2 induces targeted migration and may play a role in brain metastasis of breast cancer cells

VRP immunotherapy targeting neu: treatment efficacy and evidence for immunoediting in a stringent rat mammary tumor model

Genetic polymorphisms of NOS3 are associated with the risk of invasive breast cancer with lymph node involvement

Validation of the simplified Chinese version of the FACT-B for measuring quality of life for patients with breast cancer

Risk of second non-hematological malignancies among 376,825 breast cancer survivors

Neu im Fachgebiet Onkologie

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

Update Onkologie